Jing Cao

Dr. Jing Cao


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
LHLi Huimin
Li Huimin
JCJing Cao
Jing Cao
Andrzej GrzybowskiAndrzej Grzybowski
Andrzej Grzybowski
Kai JinKai Jin
Kai Jin
LLLixia Lou
Lixia Lou
JYJuan Ye
Juan Ye
The advent of artificial intelligence (AI), especially the state-of-the-art deep learning frameworks, has begun a silent revolution in all medical subfields, including ophthalmology. Due to their specific microvascular and neural structures, the eyes are anatomically associated with the rest of the body. Hence, ocular image-based AI technology may be a useful alternative or additional screening strategy for systemic diseases, especially where resources are scarce. This review summarizes the current applications of AI related to the prediction of systemic diseases from multimodal ocular images, including cardiovascular diseases, dementia, chronic kidney diseases, and anemia. Finally, we also discuss the current predicaments and future directions of these applications.

2 September 2025 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
YHYingcheng He
Yingcheng He
JZJingxin Zhou
Jingxin Zhou
JWJiawei Wang
Jiawei Wang
SHShenyu Huang
Shenyu Huang
HLHuimin Li
Huimin Li
JYJuan Ye
Juan Ye
Evidence on the association between visceral obesity and diabetic retinopathy (DR) remains sparse and debatable. We aimed to use three novel indicators, body roundness index (BRI), lipid accumulation product (LAP), and visceral adiposity index (VAI), to investigate the longitudinal relationship between visceral obesity and DR, and explore the potential metabolic mechanisms. In this prospective study based on the UK Biobank (UKB), 14,738 individuals with diabetes free of DR at baseline were included. Cox proportional hazards regression models were adopted to explore the association among the three indices and DR. Based on nuclear magnetic resonance (NMR) metabolomics of 168 plasma metabolites, we performed elastic net regression to select metabolites associated with visceral obesity and DR. Enrichment and pathway analyses were used to investigate biological pathways and network analysis was performed to discover the metabolic interactions. Over a 10-year follow-up, 1594 subjects developed DR. In the fully adjusted models, the three indices were significantly correlated with a high risk of DR, especially in Caucasians. Furthermore, we identified a metabolic fingerprint comprising 12 biomarkers associated with visceral obesity and DR, including 3-hydroxybutyrate, acetone, alanine, albumin, citrate, intermediate-density lipoprotein particles, creatinine, glucose, glycine, glycoprotein acetyls, pyruvate, and tyrosine. These metabolites were mainly enriched in alanine metabolism and their interaction was partly through succinic acid. Visceral obesity indices (BRI, LAP, and VAI) were positively associated with DR onset in patients with DM, and the potential mechanism involves alanine and energy metabolism. Our findings may promote early detection and precision prevention of DR.

5 December 2025 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
JWJiawei Wang
Jiawei Wang
JZJingxin Zhou
Jingxin Zhou
YHYingcheng He
Yingcheng He
SHShenyu Huang
Shenyu Huang
HLHuimin Li
Huimin Li
JYJuan Ye
Juan Ye
Hyperglycemic individuals, who are prone to microvascular complications of diabetes (MCDs) like diabetic patients, may benefit from timely carbohydrate int